Linganisha mbinu

	FACT-Anemia: Tathmini ya Kazi ya Matibabu ya Kansa	FACT-Prostate: Tathmini ya Utendaji ya Tiba ya Saratani
Nyanja	Onkolojia	Onkolojia
Familia	Process / pipeline	Process / pipeline
Mwaka wa asili	1997	1997
Mwanzilishi	Yellen, S. B., Cella, D. F., et al. (built on Cella, D. F. FACT-G framework)	Esper, P., et al. (built on Cella, D. F. FACT-G framework)
Aina	Self-report questionnaire	Self-report questionnaire
Chanzo asilia	Yellen, S. B., Cella, D. F., Webster, K., Blendowski, C., & Kaplan, E. (1997). Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage, 13(2), 63–74.	Esper, P., Mo, F., Chodak, G., Sinner, M., Cella, D., & Pienta, K. J. (1997). Measuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy-Prostate instrument. Urology, 50(6), 920–928.
Majina mbadala	FACT-An	FACT-P
Zinazohusiana	5	5
Muhtasari	The FACT-Anemia (FACT-An) is a quality-of-life measure combining the 27-item FACT-G core with a disease-specific subscale focusing on fatigue and anemia-related symptoms common in cancer patients receiving chemotherapy or dealing with cancer-induced anemia. Developed by Yellen et al. in 1997, it quantifies the impact of chemotherapy-induced anemia on functional and emotional well-being, supporting clinical trials and anemia treatment research.	The FACT-Prostate (FACT-P) is a disease-specific quality-of-life instrument for men with prostate cancer, combining the 27-item FACT-G core with a 12-item prostate-specific subscale addressing urinary, sexual, and bowel function concerns. Developed and validated by Esper et al. in 1997, it is a standard outcome measure in prostate cancer clinical trials and clinical practice.